Abstract
AimTo evaluate the therapeutic uses of Achillea millifolium in diabetic rats. MethodsDiabetes was induced by single intraperitoneal injection of freshly prepared solution of alloxan monohydrate (150 mg·kg−1 body weight) in Wistar rats of 150-200 g body weight. In this study, the aqueous and methanolic extract of Achillea millifolium was studied for its hypoglycemic and hypolipidemic properties. The rats were divided into several groups, serving as Normal group, Diabetic Control group, Diabetic treated with glibenclamide, and extract treated groups. The blood serum collected from the various groups of rats was analysed for its various biochemical parameters like glucose, cholesterol, triglycerides, VLDL, SGOT, SGPT and ALP. On the 14th day of the experiment the rats were scarified and pancreas was collected for histopathological studies. ResultsThe extracts at dose levels of 250 and 500 mg·kg−1 body weight showed significant (P ≤ 0.05) decrease in blood glucose level, TGL, VLDL, cholesterol, SGOT, SGPT, and ALP in diabetic rats. The extracts prevented the β-cells of pancreas from the cytotoxic effects of Alloxan monohydrate. ConclusionThe results indicate that the extracts as mentioned above are effective in hyperglycemia and can effectively protect against other metabolic aberrations caused by alloxan monohydrate.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
